Skip to content

NuSynth raises ₹36.5 Cr seed in specialty chemicals push

·StartupReader editorial desk· 2 min readReviewed by our editors
FUNDING. ₹36.5 Cr raised by NuSynth Technologies, specialty chemicals startup. led by Avaana Capital, Shastra VC. Bengaluru.

Bengaluru-based specialty chemicals startup NuSynth Technologies has raised ₹36.5 Cr ($4 Mn) in a seed round co-led by Avaana Capital and Shastra VC. The funding, reported by Inc42, is among the larger seed rounds in India’s deeptech space this quarter.

The startup’s focus on specialty chemicals could suggest alignment with trends in industrial and materials investing, though broader venture capital deployment remains selective. India’s Q3 2026 startup funding rose 5% year-over-year, per Inc42’s report, with gains potentially concentrated in sectors perceived as less capital-intensive or with clearer commercialization paths. Specialty chemicals might appeal to investors due to their applications in industries like pharmaceuticals, agrochemicals, and electronics.

The round includes participation from Avaana Capital, which has previously backed startups in areas like renewable materials and industrial decarbonization, and Shastra VC, a firm with a stated focus on early-stage science and engineering ventures. Neither firm’s investment history with NuSynth was listed in StartupReader’s directory.

Seed rounds of this size in deeptech sometimes indicate plans for pilot production or regulatory approvals, though NuSynth has not disclosed specific capital deployment plans. The company has also not shared milestones or revenue figures. The coming months may show whether NuSynth can translate investor backing into commercial progress—or if it will seek follow-on funding in a cautious market.

Sources: inc42.com · inc42.com

“This seed round may signal investor interest in deeptech plays in India’s industrial sector amid broader funding caution.”
— StartupReader
ShareLinkedInXWhatsApp

Read the original reporting

The outlets below did the original reporting.

Related briefs

This brief was drafted automatically from the sources above and published under our editorial policy. Spotted an error? Tell us.